Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Choosing between price and cap weighting depends on your objectives and risk tolerance. This guide highlights strengths and trade-offs.
26,516 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
U.S. stocks wobbled Friday as the Russell 2000 slipped, but the small-cap rally remains a defining thread of 2026. In...
February can feel like a shifting tide for the S&P 500. This guide shares how to invest smartly this month with a cle...
SPYM and QQQ offer different paths to U.S. stock exposure. This guide explains when SPYM might fit a portfolio better...
As markets shift away from giant tech names, a Vanguard built market approach centers on value, dividends, and steady...
SpaceX joined the Nasdaq-100 with high expectations, but the first day brought a meaningful pullback. This guide brea...
SpaceX leaps past the $2 trillion mark as it eyes a spot in the Nasdaq-100, triggering intense debate about the susta...
If you want amplified daily moves, SPXL and TQQQ offer two very different paths. This guide breaks down costs, risk, ...
Stocks ended mixed as the Dow stayed relatively calm while Nasdaq slipped. Earnings, rates, and sector rotation shape...
The S&P 500’s top ten names now control a record share of the index, a dynamic that could ripple into Bitcoin and the...
Mortgage activity rose across refinancing and buying, as the MBA reports a rebound in applications for the week endin...
A hypothetical SpaceX Nasdaq move could quietly lift required minimum distributions for retirees. This piece breaks d...